Blood test may boost colon cancer screening in those who skip it
NCT ID NCT07436637
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This study looks at whether offering a blood test (Guardant Shield) can increase colon cancer screening in people who are overdue. About 500 adults aged 45-85 will either get a standard reminder to screen or also have the option to give a blood sample. The goal is to see if the blood test option leads to more people completing screening within 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Guardant Shield blood test
- What this could lead to
- If successful, this could show that a simple blood test helps more people get screened for colon cancer, potentially catching it earlier.
- What could go wrong
- This is a small, early-stage study focused on screening uptake, not on proving the blood test's accuracy or long-term benefits. The test may not replace colonoscopy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?